Alpha Tau Medical (NASDAQ:DRTSW – Get Free Report) is expected to be issuing its results before the market opens on Thursday, March 5th. Analysts expect the company to announce earnings of ($0.1235) per share for the quarter.
Alpha Tau Medical Stock Performance
DRTSW opened at $1.15 on Wednesday. The stock’s 50 day simple moving average is $0.87 and its 200-day simple moving average is $0.51. Alpha Tau Medical has a 1 year low of $0.13 and a 1 year high of $1.50.
Alpha Tau Medical Company Profile
Alpha Tau Medical Ltd. is a clinical-stage medical technology company focused on the development of alpha-emitting radiation therapy for the treatment of solid tumor cancers. The company’s proprietary Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy) platform leverages the short-range, high-energy alpha particles emitted by radium-224 to penetrate tumor tissues more effectively than conventional external-beam radiation. By implanting thin, needle-like sources directly into a tumor, Alpha DaRT delivers concentrated doses of radiation to malignant cells while sparing surrounding healthy tissue.
The Alpha DaRT technology is designed to enhance local tumor control in a variety of solid tumors, including head and neck, breast, skin, and pancreatic cancers.
Featured Stories
- Five stocks we like better than Alpha Tau Medical
- New Copper-Rich “Kraken” Zone Discovered
- Silver Is the New Oil—And the World’s Running Dry
- America’s 1776 happening again
- 3 Signs You May Want to Switch Financial Advisors
- Trade this between 9:30 and 10:45 am EST
Receive News & Ratings for Alpha Tau Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alpha Tau Medical and related companies with MarketBeat.com's FREE daily email newsletter.
